GlyNAC Shielded Diabetic Rat Hearts From Scarring—With One Catch
A new rat study found that glycine plus NAC, the pairing behind the GlyNAC trend, best preserved heart structure and cut key stress signals in diabetic animals. But the combo didn't win every round, because NAC alone did better on some oxidative-stress markers. This was a streptozotocin-induced diabetes model in 34 rats, not human evidence. Here's what the researchers found, why rat mg/kg doses can't be translated to people, and what NAC cautions to know about.
The GlyNAC Trial That Didn't Raise Glutathione, Except in One Group
A 114-person randomized trial of GlyNAC, the glycine plus NAC combo pitched as an anti-aging glutathione booster, failed to raise glutathione in healthy older adults. Doses of 2.4, 4.8 and 7.2 g/day at a 1:1 ratio did nothing for the primary endpoint after two weeks. But a post-hoc subgroup with high oxidative stress and low baseline glutathione did see a rise at the medium and high doses. The Nestlé-run study raises a sharper question than whether GlyNAC works: for whom might it work? Here is what the trial showed, what it can't tell us, and how to read the responder signal.